Back to search

Denmark· DK-28105036912

Ziprasidon "Krka"

A ziprasidone product containing ziprasidon, registered in Denmark by KRKA, d.d., Novo mesto. The same ATC class is registered in 14 of our 19 countries.

ATC N05AE04

Checked against Danish Medicines Agency (Denmark) on

Informational only — not a medical device.

SOURCE REGISTER · DKDanish Medicines Agency (Denmark)normalisedZiprasidon "Krka"ATCN05AE04REGISTER NO.DK-28105036912PACKS LISTED1CHECKEDSeptember 30, 2026

Where it is registered

Ziprasidone is registered in 14 of 19 countries.

Countries holding a registration under ATC N05AE04 (ziprasidone), each read from that country’s own register.

  • This record: Denmark, from Danish Medicines Agency (Denmark)
  • 8 of them publish a price we can compare per daily dose

Ziprasidone · ATC N05AE04

14 / 19 countries

  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of ziprasidone costs, country by country.

Normalised to the WHO defined daily dose (80 mg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Ziprasidone · price per daily dose (80 mg)

USD · FX 28 Sept 2026

  • US United States$0.54 (acquisition cost)
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

Danish Medicines Agency (Denmark)
Active substance
ZIPRASIDON
Manufacturer
KRKA, d.d., Novo mesto
Country
Denmark (DK)
ATC code
N05AE04
ATC class
Ziprasidone
Defined daily dose
80 mg, O
Reimbursed
Not published by this register
Source register
Danish Medicines Agency (Denmark)
Last checked
September 30, 2026

Packs & prices · 1

  • dk_varenummer
    28105036912

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

403 interactions on record for ziprasidone.

Graded by severity as the source publishes them — 147 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Ziprasidone · interactions on record

403 records

  • 147 severe
  • 162 moderate
  • 38 minor
  • 56 info

Most severe, free to view

  • PapaverineA03AD01severe
  • MetoclopramideA03FA01severe
  • CisaprideA03FA02severe
  • OndansetronA04AA01severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/cd24c79a-63d0-4607-b392-e37498684b9f
GET /v1/drugs/cd24c79a-63d0-4607-b392-e37498684b9f?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "kapsler, hårde",
  "source": "dkma",
  "strength": "80 mg",
  "auth_role": "CMS",
  "dk_drugid": "28105036912",
  "substance": "ZIPRASIDON",
  "auth_procedure": "MRP",
  "in_medicinpriser": true,
  "registration_date_serial": "41102"
}

See everything about ziprasidone.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.